Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	6,505	7,090	16,169	18,626	20,592	12,613
Market Cap Growth	-25.27%	-56.15%	-13.19%	-9.54%	63.27%	28.33%
Enterprise Value	34,011	32,164	39,765	42,351	40,514	28,904
Last Close Price	27.80	30.30	67.36	76.63	83.74	50.68
PE Ratio	-	-	50.83	29.06	24.34	13.43
PS Ratio	2.01	1.74	1.52	1.34	2.13	1.16
PB Ratio	0.29	0.33	0.70	0.83	0.99	0.63
P/TBV Ratio	0.31	0.35	0.75	0.89	1.07	0.68
P/FCF Ratio	8.29	21.04	-	-	-	-
P/OCF Ratio	7.91	6.42	10.19	7.47	17.73	4.87
EV/Sales Ratio	10.53	7.88	3.74	3.04	4.19	2.67
EV/EBITDA Ratio	65.95	47.77	26.51	26.91	35.29	11.43
EV/EBIT Ratio	-	575.42	42.80	42.65	60.01	18.79
EV/FCF Ratio	43.35	95.45	-	-	-	-
Debt / Equity Ratio	1.16	1.19	1.03	0.98	0.90	0.84
Debt / EBITDA Ratio	51.52	37.20	15.66	13.74	15.87	6.59
Debt / FCF Ratio	33.36	76.20	-	-	-	-
Asset Turnover	0.06	0.07	0.20	0.28	0.21	0.27
Inventory Turnover	1.18	1.69	5.04	7.12	5.01	6.10
Quick Ratio	1.79	1.79	1.89	1.64	1.59	2.14
Current Ratio	2.08	2.07	2.24	2.01	1.99	2.70
Return on Equity (ROE)	-2.76%	-2.18%	1.55%	3.22%	4.36%	5.73%
Return on Assets (ROA)	-0.06%	0.06%	1.08%	1.23%	0.93%	2.43%
Return on Capital (ROIC)	-0.07%	0.07%	1.27%	1.48%	1.11%	2.75%
Return on Capital Employed (ROCE)	-0.10%	0.10%	2.00%	2.30%	1.70%	4.20%
Earnings Yield	-8.31%	-5.86%	1.97%	3.44%	4.11%	7.45%
FCF Yield	12.06%	4.75%	-2.24%	-7.33%	-7.31%	-13.36%
Dividend Yield	3.60%	-	1.48%	1.31%	1.19%	2.37%
Payout Ratio	-	-	84.84%	23.86%	38.36%	36.22%
Total Shareholder Return	3.60%	-	1.48%	1.31%	1.19%	2.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.